MX9704105A - Conjunto para uso en un ciclo terapeutico de tratamiento de la osteoporosis. - Google Patents

Conjunto para uso en un ciclo terapeutico de tratamiento de la osteoporosis.

Info

Publication number
MX9704105A
MX9704105A MX9704105A MX9704105A MX9704105A MX 9704105 A MX9704105 A MX 9704105A MX 9704105 A MX9704105 A MX 9704105A MX 9704105 A MX9704105 A MX 9704105A MX 9704105 A MX9704105 A MX 9704105A
Authority
MX
Mexico
Prior art keywords
kit
treatment cycle
osteoporosis treatment
osteoporosis
therapeutical
Prior art date
Application number
MX9704105A
Other languages
English (en)
Other versions
MXPA97004105A (es
Inventor
Martine Gazard
Olivier Gros
Jacques Girard
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of MX9704105A publication Critical patent/MX9704105A/es
Publication of MXPA97004105A publication Critical patent/MXPA97004105A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)

Abstract

La invencion se relaciona con un conjunto para uso en un ciclo terapéutico basado en la administracion secuencial de ácido tiludronico o una sal y/o solvato del mismo y de calcio durante 28 a 31 días para el tratamiento y/o la prevencion de la osteoporosis.
MXPA/A/1997/004105A 1994-12-06 1997-06-03 Conjunto para uso en un ciclo terapeutico de tratamiento de la osteoporosis MXPA97004105A (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
FR94/14630 1994-12-06
FR9414630 1994-12-06
FR9414630A FR2727629A1 (fr) 1994-12-06 1994-12-06 Trousse pour cycle de traitement de l'osteoporose
PCT/FR1995/001596 WO1996017616A1 (fr) 1994-12-06 1995-12-05 Trousse pour cycle de traitement de l'osteoporose

Publications (2)

Publication Number Publication Date
MX9704105A true MX9704105A (es) 1997-09-30
MXPA97004105A MXPA97004105A (es) 1998-07-03

Family

ID=

Also Published As

Publication number Publication date
ZA9510184B (en) 1996-06-11
WO1996017616A1 (fr) 1996-06-13
BR9509961A (pt) 1997-11-25
FI972383A0 (fi) 1997-06-05
FR2727629B1 (es) 1997-02-28
SK68597A3 (en) 1997-11-05
EP0797444A1 (fr) 1997-10-01
AU4307396A (en) 1996-06-26
NO972558L (no) 1997-08-05
PL320564A1 (en) 1997-10-13
JPH10509729A (ja) 1998-09-22
FI972383A (fi) 1997-06-05
IL116168A0 (en) 1996-01-31
FR2727629A1 (fr) 1996-06-07
AR002946A1 (es) 1998-05-27
MA23737A1 (fr) 1996-07-01
CN1168634A (zh) 1997-12-24
TR199501530A1 (tr) 1996-10-21
NO972558D0 (no) 1997-06-05
CZ175397A3 (en) 1997-10-15
CA2207028A1 (en) 1996-06-13
HUT77382A (hu) 1998-04-28
KR980700083A (ko) 1998-03-30

Similar Documents

Publication Publication Date Title
UA42747C2 (uk) Похідні пептиду,фармацевтична композиція та спосіб стимулювання секреції гормону росту
GR970100477A (el) Νεα συνθεση
EP0511868A3 (en) Medical or dental hardening compositions
MX9704030A (es) 1,1-dioxidos de 2-heterocicliloxi y tiometil-1,2,5-tiadiazolidin-3-ona y composiciones y metodo de uso de los mismos.
IL113566A0 (en) Use of certain methanebisphosphonic acid derivatives to prevent prosthesis loosening and prosthesis migration
UA41355C2 (uk) Засіб для лікування нейро-сніду
ZA933768B (en) Novel phosphonosulfonate compounds, pharmaceutical compositions, and methods for treating abnormal calcium and phosphate metabolism metabolism.
SG44640A1 (en) Chelants possessing ortho ligating functionality and complexes thereof
KR100213963B1 (en) Use of 2,3-diaryl-1-benzopyran derivatives for the manufacture of a medicament in the treatment and prevention of bone loss and osteoporosis
MX9703944A (es) Metodo para usar derivados de triaril-etileno en el tratamiento y prevencion de osteoporosis.
PL338673A1 (en) Application of fanquinone in treating alzheimer disease
NZ326345A (en) Composition containing diosgenin
GR3007995T3 (es)
MX9704105A (es) Conjunto para uso en un ciclo terapeutico de tratamiento de la osteoporosis.
GB9108634D0 (en) Pharmaceutical compositions
ZA891894B (en) Composition for the treatment of osteoporosis in humans
UA29461C2 (uk) Засіб для лікування амілоїдозу, спосіб лікування амілоїдозу
SI0711163T1 (en) Use of benzydamine in the treatment of pathological conditions caused by tnf
GR3022935T3 (en) Product and use of it for the treatment of catabolic states comprising authentic igf-1 and hypocaloric amount of nutritients
HK44597A (en) Use of chlormethiazole in the manufacture of a medicament for the prevention and/or treatment of neurodegeneration
SE9303740L (sv) Farmaceutisk komposition
IT1242026B (it) Composizione farmaceutica contenente un complesso ferro-schizokinene per il trattamento dell'anemia ferropenica.
UA30203A (uk) Спосіб лікування хронічного мієлолейкозу
GB8628357D0 (en) Chelating agents synergistic treatment